Sotorasib
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Sotorasib
Jul 12, 2024, 14:18 |
Blog
Updated review on targeting KRAS in NSCLC
Stephen V Liu shared on X: "Updated review on targeting KRAS in NSCLC available in…
Jul 12, 2024, 11:24 |
Insight
What comes after sotorasib and adagrasib?
Aakash Desai, Thoracic/Phase 1 Oncologist at UAB O'Neal Comprehensive Cancer Center, shared a post on…
Jul 10, 2024, 16:42 |
Blog
Yakup Ergün: The effects of 960 mg sotorasib
Tejas Patil, Thoracic oncologist CU Cancer Center, shared a post by Yakup Ergün, Medical Oncologist at Antalya…
Jul 2, 2024, 04:16 |
Insight
Olivier Calvayrac: TT-derived drug-tolerant (DT) lung cancer cells are vulnerable to FTIs
Olivier Calvayrac, Research Scientist at the Toulouse Cancer Research Center, shared a post on X…
May 5, 2024, 07:48 |
Blog
Timothée Olivier: The regulatory failure of sotorasib in lung!
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals shared a thread on X:…
May 4, 2024, 16:54 |
Insight
Elizabeth McKenna: The May issue of Cancer Discovery
Elizabeth McKenna shared on LinkedIn: "The May issue of Cancer Discovery is now online! The…
Apr 11, 2024, 17:17 |
Insight
Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management
Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices…
Apr 6, 2024, 07:14 |
Drugs
Antonio Passaro: Why is this press release of Bristol Myers Squibb so crucial for our community?
Antonio Passaro, Medical Director at the Institute of European Oncology (IEO), shared a post on…
Jan 10, 2024, 18:21 |
Blog
Top Precision Oncology articles of 2023 by Vivek Subbiah
Vivek Subbiah shared on X/Twitter: "By popular demand delighted to share the 'Top Precision Oncology…
Oct 7, 2023, 18:27 |
Opinion
Bishal Gyawali: This offers a good lesson on why oncology KOLs are not always the best person to interpret the results of a trial.
Quoting Bishal Gyawali, Associate Professor at Queen’s University, on LinkedIn: “This is from FDA’s ODAC…
Sep 27, 2023, 18:18 |
Insight
Aakash Desai: Out in Journal of Thoracic Oncology our editorial “Toxicity From Sotorasib after ICI: A Note of Caution and Reflections of Future Advancements in the Field”.
All:
11
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube